Indiana § 16-42-26.5-4 Qualification requirements

Indiana Statutes

§ 16-42-26.5-4 — Qualification requirements

Indiana § 16-42-26.5-4

Title 16HEALTH

Art. 42REGULATION OF FOOD, DRUGS, AND

Ch. 26.5Individualized Investigational Treatment

This text of Indiana § 16-42-26.5-4 (Qualification requirements) is published on Counsel Stack Legal Research, covering Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ind. Code § 16-42-26.5-4 (2026).

Text

An individual must meet the following requirements in order to qualify as an eligible patient under this chapter:

(1)Has been diagnosed with a life threatening or severely debilitating disease, as attested by the individual's physician.

(2)Has considered other treatment options currently approved by the United States Food and Drug Administration.

(3)Has received a recommendation from the individual's physician for an individualized investigational treatment based on analysis of the patient's genomic sequence, human chromosomes, deoxyribonucleic acid, ribonucleic acid, genes, gene products, or metabolites.

(4)Has given written informed consent as set forth in section 5 of this chapter for the use of the individualized investigational treatment.

(5)Has documentation from the individual'

Free access — add to your briefcase to read the full text and ask questions with AI

An individual must meet the following
requirements in order to qualify as an eligible patient under this
chapter:
(1) Has been diagnosed with a life threatening or severely
debilitating disease, as attested by the individual's physician.
(2) Has considered other treatment options currently approved by
the United States Food and Drug Administration.
(3) Has received a recommendation from the individual's
physician for an individualized investigational treatment based on
analysis of the patient's genomic sequence, human chromosomes,
deoxyribonucleic acid, ribonucleic acid, genes, gene products, or
metabolites.
(4) Has given written informed consent as set forth in section 5 of
this chapter for the use of the individualized investigational
treatment.
(5) Has documentation from the individual's physician that the
individual meets the requirements of this section.